Section Arrow
Quote
LXRX.NASDAQ
- Lexicon Pharmaceuticals
(Financial Status)
Quotes are at least 15-min delayed:2025/03/28 00:17 EDT
Last
 0.3476
+0.0186 (+5.65%)
Day High 
0.349 
Prev. Close
0.329 
1-M High
0.7273 
Volume 
3.77M 
Bid
0.3401
Ask
0.348
Day Low
0.325 
Open
0.329 
1-M Low
0.2836 
Market Cap 
118.93M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.36 
20-SMA 0.39 
50-SMA 0.61 
52-W High 2.47 
52-W Low 0.2836 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.63/-0.39
Enterprise Value
226.15M
Balance Sheet
Book Value Per Share
0.40
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
31.08M
Operating Revenue Per Share
0.00
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
OCEAOcean Biomedical0.078-0.0057-6.81%-- 
DRMADermata Therapeutics Inc.1.42+0.07+5.19%-- 
ONCOOnconetix Inc0.1077+0.0017+1.60%-- 
RGLSRegulus Therapeutics1.5+0.21+16.28%-- 
NKTXNkarta1.97+0.6+43.80%-- 
Quotes are at least 15-min delayed：2025/03/28 00:17 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.